title: Evidence for regulated coupling of A1 adenosine receptors by phosphorylation in Zucker rats.
abstract: Studies were designed to find the molecular basis for previous observations that lipolysis is less active and A1 adenosine receptor signaling is more active in adipocytes from obese than from lean Zucker rats. With quantitative immunoblot procedures for detection, Gi alpha 1 and Gs alpha 45 levels were found anomalously low in obese compared with lean membranes (50 and 30%, respectively), but other G alpha subunit levels were normal. However, the sensitivity of the receptor-Gi protein to GTP was about 5- to 10-fold higher in obese compared with lean membranes when assessed from 1) the ability of GTP to inhibit forskolin-stimulated adenylyl cyclase in the presence of an adenosine receptor agonist and 2) the ability of a nonhydrolyzable guanine nucleotide analogue to alter A1 adenosine receptor agonist binding. Alkaline phosphatase treatment of isolated adipocyte membranes from obese but not lean animals decreased guanine nucleotide sensitivity of agonist binding. Surprisingly, solubilized adipocyte A1 adenosine receptors from all animals exhibited the same high sensitivity to guanine nucleotides as that of intact obese membranes, and this high sensitivity could be decreased 20-fold by treatment with alkaline phosphatase. These data suggest that protein phosphorylation may regulate coupling of the A1 adenosine receptor in rat adipocyte membranes.
authors.affiliation: Department of Cellular and Molecular Physiology, Hershey Medical Center, Pennsylvania State University 17033, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Berkich
authors.forename: D R
authors.initials: DR
authors.lastname: Luthin
authors.forename: R L
authors.initials: RL
authors.lastname: Woodard
authors.forename: S J
authors.initials: SJ
authors.lastname: Vannucci
authors.forename: J
authors.initials: J
authors.lastname: Linden
authors.forename: K F
authors.initials: KF
authors.lastname: LaNoue
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives / Q000378:metabolism; D000262:Adenylyl Cyclases / Q000378:metabolism; D017667:Adipocytes / Q000378:metabolism; D000818:Animals; D002462:Cell Membrane / Q000378:metabolism; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000096:biosynthesis; D006150:Guanine Nucleotides / Q000494:pharmacology; D006160:Guanosine Triphosphate / Q000494:pharmacology; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D007457:Iodine Radioisotopes; D007462:Iodobenzenes / Q000378:metabolism; D009765:Obesity / Q000378:metabolism*; D010766:Phosphorylation; D011506:Proteins / Q000378:metabolism; D058906:Purinergic P1 Receptor Agonists; D051381:Rats; D017207:Rats, Sprague-Dawley; D011924:Rats, Zucker / Q000378:metabolism*; D018047:Receptors, Purinergic P1 / Q000378:metabolism*
chemical_list: D006150:Guanine Nucleotides; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D011506:Proteins; D058906:Purinergic P1 Receptor Agonists; D018047:Receptors, Purinergic P1; D005576:Colforsin; D006165:Guanylyl Imidodiphosphate; D006160:Guanosine Triphosphate; C044323:3-iodo-N(6)-4-aminobenzyladenosine; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D000241:Adenosine